We propose the use of Structured Light Imaging Mesoscopy (SLIM) as a novel wide-field diffuse optical imaging method to track skin involvement in scleroderma, a chronic, autoimmune disorder characterized by fibrosis. Clinical SLIM measurements were conducted on 25 SSc patients and 18 healthy controls at a series of wavelengths and spatial frequencies. Monte-Carlo simulations were conducted on a multi-layer skin model with clinically relevant perturbations, and results were compared with clinical SLIM data. We found that SLIM measurements at 851 nm and 0.2 /mm could be used to assess skin involvement in scleroderma for various melanin concentrations.